US Patent 11096619 Neural analysis and treatment system
Patent 11096619 was granted and assigned to Innara Health on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+617 characters)
Article
Patent abstract
A neural analysis and treatment system includes a computing device with a memory for storing an application that is executable on a processor to receive amplitude-integrated electroencephalography (aEEG) and range-EEG (rEEG) measurements associated with a patient. The systems determine a spectral edge frequency (SEF) measurement from the received EEG measurements, and determine one or more neural characteristics of the patient according to the determined SEF, aEEG, and rEEG measurements. These neural characteristics may then be used to identify and implement an appropriate therapeutic treatment.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David L. Stalling0
Kenneth Aron0
Steven M. Barlow0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110966190
Date of Patent
August 24, 2021
0Patent Application Number
201407140
Date Filed
July 14, 2014
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11096619 Neural analysis and treatment system
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11096619
Date of patent
August 24, 2021
Patent application number
20140714
Date Filed
July 14, 2014
Find more entities like US Patent 11096619 Neural analysis and treatment system
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.